Amalgamated Bank Sells 2,306 Shares of Doximity, Inc. (NASDAQ:DOCS)

Amalgamated Bank cut its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 3.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,399 shares of the company’s stock after selling 2,306 shares during the period. Amalgamated Bank’s holdings in Doximity were worth $2,588,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. LRI Investments LLC bought a new stake in shares of Doximity during the 1st quarter worth $27,000. Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after acquiring an additional 603 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of Doximity by 621.4% in the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP grew its holdings in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after purchasing an additional 131,253 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Doximity during the 1st quarter worth approximately $46,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DOCS. Canaccord Genuity Group boosted their target price on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. KeyCorp raised Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Friday. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Friday, August 9th. JPMorgan Chase & Co. upped their price objective on Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research note on Monday, August 19th. Finally, Morgan Stanley boosted their target price on shares of Doximity from $26.00 to $33.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Doximity has an average rating of “Moderate Buy” and a consensus price target of $43.92.

Doximity Stock Up 34.2 %

Shares of DOCS stock opened at $58.25 on Monday. Doximity, Inc. has a 12-month low of $20.28 and a 12-month high of $60.90. The company has a 50 day moving average of $41.55 and a 200-day moving average of $33.17. The firm has a market cap of $10.81 billion, a P/E ratio of 72.81, a PEG ratio of 5.09 and a beta of 1.30.

Doximity (NASDAQ:DOCS) last issued its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.06. The firm had revenue of $126.68 million for the quarter, compared to analyst estimates of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. As a group, equities analysts expect that Doximity, Inc. will post 0.8 EPS for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.